HowardLeeFoytMD

Diabetes, Lipid Metabolism

Physician

Dr. Foyt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1991
Baylor College of MedicineResidency, Internal Medicine, 1985 - 1988
Baylor College of MedicineClass of 1985

PubMed

74 citations
The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multic...
Jean-François Yale, Thomas R. Valiquett, Mahmoud N. Ghazzi, Janet K. Owens-Grillo, Randall W. Whitcomb
Annals of Internal Medicine. 2001-05-01
14 citations
Encapsulated stem cell-derived β cells exert glucose control in patients with type 1 diabetes.
Bart Keymeulen, Kaat De Groot, Daniel Jacobs-Tulleneers-Thevissen, David M Thompson, Melena D Bellin
Nature Biotechnology. 2024-10-01
119 citations
Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device
A. M. James Shapiro, David M. Thompson, Thomas Donner, Melena D. Bellin, Willa A. Hsueh
Cell Reports. Medicine. 2021-12-02

San Diego Biotech Working on ‘Functional Cure’ for Type 1 Diabetes Sold to Rival for $320MJuly 12th, 2022
Vertex to Acquire ViaCyte for $320M, Growing Diabetes Cell Therapy PipelineJuly 11th, 2022
ViaCyte Appoints Dr. Jon Wilensky as Head of SurgeryJuly 21st, 2021
Join now to see all